2018
DOI: 10.1016/j.atherosclerosis.2018.08.005
|View full text |Cite
|
Sign up to set email alerts
|

Gender differences in the association of syndecan-4 with myocardial infarction: The population-based Tromsø Study

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

3
23
1

Year Published

2019
2019
2024
2024

Publication Types

Select...
9

Relationship

2
7

Authors

Journals

citations
Cited by 26 publications
(27 citation statements)
references
References 46 publications
3
23
1
Order By: Relevance
“…Considering that the relationship between body fat mass and various cardiometabolic risk factors also vary by sex in humans [60], our results may have a high relevance to human health. This is further supported by observations from a recent study, showing that serum levels of SDC4 were significantly associated with myocardial infarction in women [61]. In addition, high levels of SDC4 gene expression are significantly associated with estrogen receptor-positive breast carcinomas [62], corroborating the notion of a relationship between SDC4 and estrogen/estrogen receptor signaling.…”
Section: Discussionsupporting
confidence: 80%
“…Considering that the relationship between body fat mass and various cardiometabolic risk factors also vary by sex in humans [60], our results may have a high relevance to human health. This is further supported by observations from a recent study, showing that serum levels of SDC4 were significantly associated with myocardial infarction in women [61]. In addition, high levels of SDC4 gene expression are significantly associated with estrogen receptor-positive breast carcinomas [62], corroborating the notion of a relationship between SDC4 and estrogen/estrogen receptor signaling.…”
Section: Discussionsupporting
confidence: 80%
“…MV were recovered in medium from untreated cells, most likely indicating spontaneous release of MV during cellular homeostatic processes and is consistent with detection of the presence of low number of endothelium-derived MV in the circulation of healthy humans [27]. Except for PECAM-1, under control condition, there were greater numbers of MV in conditioned media derived from female than from male cells, perhaps reflecting differences in glycocalyx structure or cellular metabolism [39, 40].…”
Section: Discussionsupporting
confidence: 73%
“…We have also shown that increased serum concentrations of syndecan-1 are related to early diabetic nephropathy [18], and we observed a trend for increased syndecan-1 serum concentrations in hyperglycemic individuals compared to normoglycemic kidney transplanted patients together with increased levels of the syndecan sheddase matrix metalloproteinase MMP-9 [19]. Furthermore, we have demonstrated high expression of syndecan-4 in endothelial cells [20], and in a case-cohort study including 1500 participants from the Tromsø study, we observed that serum syndecan-4 was an independent predictor of myocardial infarction [21]. Although syndecan-shedding is reported to be increased in chronic hyperglycemia, shedding of syndecans in prediabetes has not been studied to a great extent.…”
Section: Introductionmentioning
confidence: 62%